s6y

IMPACT BIOMEDICAL INC.

Ticker
IBO
CIK
1834105
Industry
Pharmaceutical Preparations

Financials 14

  1. 10-Q Quarterly Report for period ending Sep 30, 2026
  2. 10-Q Quarterly Report for period ending Jun 30, 2026
  3. 10-Q Quarterly Report for period ending Mar 31, 2026
  4. 10-K Annual Report for period ending Dec 31, 2025
  5. 10-Q Quarterly Report for period ending Sep 30, 2025
  6. 10-Q Quarterly Report for period ending Jun 30, 2025
  7. 10-Q Quarterly Report for period ending Mar 31, 2025
  8. 10-K Annual Report for period ending Dec 31, 2024
  9. 10-Q Quarterly Report for period ending Sep 30, 2024
  10. 10-Q Quarterly Report for period ending Jun 30, 2024

All 14 financials filings

News 21

  1. 8-K Current report filing
  2. 8-K Current report filing
  3. 8-K Current report filing
  4. 8-K Current report filing
  5. 8-K Current report filing
  6. 8-K Current report filing
  7. 8-K Current report filing
  8. 8-K Current report filing
  9. 8-K Current report filing
  10. 8-K Current report filing

All 21 news filings

Ownership 38

  1. 4 Statement of changes in beneficial ownership of securities
  2. 4 Statement of changes in beneficial ownership of securities
  3. 4 Statement of changes in beneficial ownership of securities
  4. 4 Statement of changes in beneficial ownership of securities
  5. 4 Statement of changes in beneficial ownership of securities
  6. 4 Statement of changes in beneficial ownership of securities
  7. 4 Statement of changes in beneficial ownership of securities
  8. 4 Statement of changes in beneficial ownership of securities
  9. 4 Statement of changes in beneficial ownership of securities
  10. 4 Statement of changes in beneficial ownership of securities

All 38 ownership filings

Prospectus 30

  1. 425 Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
  2. 425 Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
  3. 425 Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
  4. S-8 POS Post-effective amendment to a S-8 registration statement
  5. S-8 POS Post-effective amendment to a S-8 registration statement
  6. S-8 Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
  7. 424B4 Prospectus filed pursuant to Rule 424(b)(4)
  8. S-1/A General form of registration statement for all companies including face-amount certificate companies
  9. S-1/A General form of registration statement for all companies including face-amount certificate companies
  10. S-1/A General form of registration statement for all companies including face-amount certificate companies

All 30 prospectus filings

Proxies 8

  1. DEFM14A Definitive proxy statement relating to a merger, acquisition, or disposition
  2. DEF 14C Definitive information statements
  3. PRE 14C Preliminary information statement not related to a contested matter or merger/acquisition
  4. DEF 14A Definitive proxy statements
  5. DEF 14C Definitive information statements
  6. PRE 14C Preliminary information statement not related to a contested matter or merger/acquisition
  7. DEF 14C Definitive information statements
  8. PRE 14C Preliminary information statement not related to a contested matter or merger/acquisition

Other 48

  1. 25-NSE Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
  2. 144 Filing for proposed sale of securities under Rule 144
  3. SCHEDULE 13D/A
  4. SCHEDULE 13D
  5. UPLOAD Letter (PDF)
  6. CORRESP A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
  7. UPLOAD Letter (PDF)
  8. CORRESP A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
  9. UPLOAD Letter (PDF)
  10. EFFECT Notice of Effectiveness

All 48 other filings